Back to top

ImmunityBio wins UAE approval for ANKTIVA cancer therapies

ImmunityBio ( ($IBRX) ) has shared an announcement. On July 29, 2026, ImmunityBio announced that the Emirates Drug Establishment of the United Arab...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ImmunityBio, Inc. (IBRX)